A. Brauers et G. Jakse, CYTOGENETIC AND MOLECULAR ALTERATIONS IND ICATIVE OF ETIOLOGY AND PROGNOSIS IN HUMAN BLADDER-CANCER, Aktuelle Urologie, 27(1), 1996, pp. 12-19
Cytogenetic and molecular alterations indicative of etiology and progn
osis in human bladder cancer: Several studies on bladder tumors have i
dentified numeric and structural aberrations on chromosomes 1, 5, 7, 8
, 9, 11, 13 and 17. Some of the reputed crucial events in the tumorige
nic process cannot be analyzed cytogenetically and afford molecular ap
proaches. Activation of proto-oncogenes such as c-erbB-1, c-erbB-2, cH
a-ras, src, inst-2, hst1 and Bcl-1,-2 and alteration of tumor suppress
or genes p53 and Rb are required for tumor development. We present an
evaluation of these parameters in terms of etiology, clinical and path
ological findings and prognosis. Evaluation of genetic parameters such
as p53, EGFR- and c-erbs-2 expression may enhance the prognosis in pa
tients with transitional cell carcinoma and provide further informatio
n about the necessity for additional therapeutic procedures.